Gossamer Bio, Inc. (GOSS)
Gossamer Bio Market Cap : 101.17M for March 13, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 520.74M |
| Madrigal Pharmaceuticals, Inc. | 10.10B |
| Kyntra Bio, Inc. | 28.17M |
| Artelo Biosciences, Inc. | 2.663M |
| Axsome Therapeutics, Inc. | 7.984B |
Market Cap Related Metrics
| PS Ratio | 2.254 |
| PEG Ratio | -0.0058 |
| Price | 0.4371 |
| Earnings Yield | -157.2% |
| PEGY Ratio | -0.0058 |